Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SP LaRosa
Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564), a TLR4 Antagonist, in Patients With Severe Sepsis
Critical Care
Critical Care
Intensive Care Medicine
Related publications
Toll-Like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury Through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Impact of Blood Glucose Abnormalities on Outcomes and Disease Severity in Patients With Severe Sepsis: An Analysis From a Multicenter, Prospective Survey of Severe Sepsis
PLoS ONE
Multidisciplinary
Influence of Severity of Illness on Neutrophil Gelatinase-Associated Lipocalin Performance as a Marker of Acute Kidney Injury: A Prospective Cohort Study of Patients With Sepsis
BMC Nephrology
Nephrology
The Effects of Steroids During Sepsis Depend on Dose and Severity of Illness: An Updated Meta-Analysis
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Using of TLR2 and TLR4 as Biomarker of Sepsis Severity Detection
Al-Mustansiriyah Journal of Science
Hyperuricemia: An Early Marker for Severity of Illness in Sepsis
International Journal of Nephrology
Nephrology
Eritoran: The Evidence of Its Therapeutic Potential in Sepsis
Core Evidence
Medicine
Reviews
References
Pharmacology
The Effects of Motivation Feedback in Patients With Severe Mental Illness: A Cluster Randomized Controlled Trial
Neuropsychiatric Disease and Treatment
Outcomes of Neutropenic Patients With Severe Sepsis on a Specialist Cancer ICU
Critical Care
Critical Care
Intensive Care Medicine
